Search research articles
Contact Us
Filters
Showing results (371-380 of 377) with videos related to
Page
of 38
Sort By:
You have reached the last page of results.
This site can display upto 377 results.
Contemporary Clinical Trials Communications
|
August 11, 2018
Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA!
Amy Bartlett, Stephen J Kolb, Allison Kingsley, et al.
Annals of Neurology
|
November 18, 2017
Natural history of infantile-onset spinal muscular atrophy
Stephen J Kolb, Christopher S Coffey, Jon W Yankey, et al.
Annals of Clinical and Translational Neurology
|
February 23, 2016
Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study
Stephen J Kolb, Christopher S Coffey, Jon W Yankey, et al.
Contemporary Clinical Trials
|
April 29, 2017
Developing standardized corticosteroid treatment for Duchenne muscular dystrophy
Michela Guglieri, Kate Bushby, Michael P McDermott, et al.
Trials
|
May 26, 2018
A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial
Rebecca A Crow, Kimberly A Hart, Michael P McDermott, et al.
JAMA Network Open
|
September 25, 2025
Olfactory Dysfunction After SARS-CoV-2 Infection in the RECOVER Adult Cohort
Leora I Horwitz, Jacqueline H Becker, Weixing Huang, et al.
JAMA
|
April 5, 2022
Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial
Michela Guglieri, Kate Bushby, Michael P McDermott, et al.
Page
of 38
Search research articles
Search
Showing results (371-380 of 377) with videos related to
Sort By:
Page
of 38
You have reached the last page of results.
This site can display upto 377 results.
Contemporary Clinical Trials Communications
|
August 11, 2018
Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA!
Amy Bartlett, Stephen J Kolb, Allison Kingsley, et al.
Annals of Neurology
|
November 18, 2017
Natural history of infantile-onset spinal muscular atrophy
Stephen J Kolb, Christopher S Coffey, Jon W Yankey, et al.
Annals of Clinical and Translational Neurology
|
February 23, 2016
Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study
Stephen J Kolb, Christopher S Coffey, Jon W Yankey, et al.
Contemporary Clinical Trials
|
April 29, 2017
Developing standardized corticosteroid treatment for Duchenne muscular dystrophy
Michela Guglieri, Kate Bushby, Michael P McDermott, et al.
Trials
|
May 26, 2018
A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial
Rebecca A Crow, Kimberly A Hart, Michael P McDermott, et al.
JAMA Network Open
|
September 25, 2025
Olfactory Dysfunction After SARS-CoV-2 Infection in the RECOVER Adult Cohort
Leora I Horwitz, Jacqueline H Becker, Weixing Huang, et al.
JAMA
|
April 5, 2022
Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial
Michela Guglieri, Kate Bushby, Michael P McDermott, et al.
Page
of 38